Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

Prevalence of Humoral Dysfunction in Pts With Frequent Exacerbations of COPD, and the Effect of SCIgR for Prevention

ClinicalTrials.gov ID: NCT05764993

Public ClinicalTrials.gov record NCT05764993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:46 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prevalence of Humoral Immune Deficiency in Patients With Frequent Exacerbations of COPD, and the Effect of Immunoglobulin Replacement on Future Exacerbations

Study identification

NCT ID
NCT05764993
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rochester General Hospital
Other
Enrollment
40 participants

Conditions and interventions

Interventions

  • CUVITRU - Ig subcutaneous human 20% Biological
  • Standard Medical Therapy Other

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 82 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2023
Primary completion
Feb 27, 2025
Completion
Dec 29, 2025
Last update posted
Jun 14, 2023

2023 – 2025

United States locations

U.S. sites
3
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Rochester Regional Health Ctr for Clinical Research - Alexander Park Rochester New York 14607 Recruiting
Rochester Regional Health - Ctr for Clinical Research - Linden Oaks Rochester New York 14625 Recruiting
Rochester Regional Health - Ctr for Clinical Research - Greece Rochester New York 14626 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05764993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 14, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05764993 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →